Healthcare101

 The global CRISPR Market , valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching US$3.21 billion in 2025 and an impressive US$5.47 billion by 2030. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years. However, technical challenges associated with CRISPR technology and regulatory hurdles for CRISPR advancements are likely to hamper the market growth in the forecast period. The key segments positively influencing the market include products, such as CRISPR kits & enzymes, which dominate due to their vital role in drug discovery and genetic research. In terms of applications, drug discovery & ...

The global gene therapy market , valued at US$7.21 billion in 2023, stood at US$8.85 billion in 2024 and is projected to advance at a resilient CAGR of 19.4% from 2025 to 2032, culminating in a forecasted valuation of US$36.55 billion by the end of the period. This advancement underscores the increasing demand for curative and precision-based therapies addressing genetic disorders, rare diseases, and specific cancer types, alongside a strong surge in clinical research investments and technology breakthroughs. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122857962 A Transformational Market Driven by Demand for Curative Solutions What is driving this growth? The industry is witnessing unprecedented momentum as biotechnology companies, pharmaceutical leaders, and research institutions race to deliver long-term disease modification and one-time treatment cures. Approximately 19 new gene therapy products are expected to launch between 2026 and 2032, contrib...

 The Global Protein Microarrays Market is projected to surge from USD 1.00 billion in 2025 to USD 1.78 billion by 2030, advancing at a compound annual growth rate (CAGR) of 12.3% over the forecast period. This near-doubling of market value underscores a fundamental shift: protein-level insights are no longer supplementary to drug discovery and diagnostics pipelines — they are central to them. What is driving this momentum? The convergence of high-throughput multiplexing technologies, laboratory automation, and advanced bioinformatics platforms is enabling researchers and clinicians to simultaneously analyze thousands of protein interactions, validate biomarkers with unprecedented precision, and predict therapeutic response across oncology, neurology, and immunology indications — compressing timelines and elevating the quality of clinical decision-making. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25942618 Why This Market Matters Now The urgency ...

Magnetic Resonance Imaging (MRI) has transformed the way clinicians diagnose and monitor spinal conditions. Among its many applications, the Spine MRI System stands out as a critical tool for evaluating complex spinal structures with unmatched clarity and accuracy. As the global burden of spinal disorders continues to rise — driven by aging populations, sedentary lifestyles, and workplace-related injuries — the demand for advanced imaging solutions like spine MRI systems is rapidly increasing. The Spine MRI System market, valued at USD 0.70 billion in 2025, stood at USD 0.74 billion in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of USD 1.07 billion by the end of the period. Download PDF Brochure What is a Spine MRI System? A Spine MRI System is a specialized application of MRI technology designed to capture high-resolution images of the spinal cord, vertebrae, intervertebral discs, and surrounding soft tissu...

 The global  Injection Pen Market  is valued at an estimated USD 47.0 billion in 2024 and is projected to reach USD 74.1 billion by 2029 at a CAGR of 7.9% during the forecast period. The global injection pens market is projected to experience sustained growth due to increasing chronic disease prevalence, the launch of advanced products, a trend towards smart devices, and supportive government policies promoting low-cost injections. Rising cases of chronic conditions like diabetes and obesity, driven by an aging population, are expected to boost demand for injection pens. However, stringent regulatory requirements and the challenge of inadequate training on new devices could impede market progress. Opportunities lie in developing patient-centric, connected devices, such as Medtronic's Bluetooth-enabled InPen. In 2023, disposable injection pens dominated the market due to their convenience and safety features, while home care settings are anticipated to ...

 The global Endoscopy Equipment Market , valued at US$34.83 billion in 2024, stood at US$37.08 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$53.54 billion by the end of the period. The growth of the endoscopy equipment market is driven by the rising need for endoscopy in diagnosing and treating critical diseases, increasing investments and grants from governments and organizations, and the growing prevalence of inflammatory bowel disease and colorectal cancer. Additionally, hospitals are expanding their endoscopic capabilities, fueled by the increasing demand for minimally invasive procedures and ongoing technological advancements. The rising adoption of single-use endoscopy instruments and the growing trend toward automated endoscope reprocessing, which enhances efficiency, reduces infection risks, and meets stringent hygiene standards, drives the endoscopy equipment market. Download PDF Broch...